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The specialized microenvironment that surrounds he-
matopoietic stem cells (HSCs) is termed as the niche,
which is a critical regulator of self-renewal and differenti-
ation of HSCs into blood and immune cell lineages
(Orkin and Zon, 2008; Morrison and Scadden, 2014; Bou-
lais and Frenette, 2015). A variety of different cell types,
adhesion molecules, and secreted signaling factors are
associated with the HSC niche that can directly affect
stem cell behavior. Detailed understanding of such
HSC-niche interactions is crucial for improving HSC
transplantation-based disease therapies. Because of the
complex interaction between the niche and HSCs,
many aspects of hematopoiesis are difficult to study in
cell culture systems. The use of vertebrate model organ-
isms such as mouse, frog, and zebrafish has substantially
helped to elucidate pathways of hematopoietic develop-
ment and regeneration. External development of lower
vertebrates such as frog and fish, as well as large numbers
of embryos per female, makes many experiments feasible
that would not be possible in placental mammals. In the
past 25 years we and others have demonstrated that both
transcriptional regulation and cellular makeup of the
hematopoietic system is largely conserved from fish to
humans (Brownlie et al., 1998; Childs et al., 2000; Dono-
van et al., 2000; Liao et al., 2000; Shafizadeh et al., 2002;
Brownlie et al., 2003; Paw et al., 2003; Paffett-Lugassy
et al., 2007). After being born from the hemogenic endo-
thelium of the dorsal aorta (DA) (Kissa et al., 2008; Ber-
trand et al., 2010; Boisset et al., 2010), definitive HSCs
enter into blood circulation and then populate an inter-
mediate hematopoietic niche before colonizing the adult
marrow. In mammals, this temporary niche is the fetal
liver, whereas in zebrafish it is the caudal hematopoietic
tissue (CHT), a thin vascular plexus in the tail region of
the embryo (Murayama et al., 2006; Orkin and Zon,
2008). Following a rapid expansion, the HSCs will egress
the temporary niche to finally colonize the adult marrow,
which inmammals are the bones and in zebrafish the kid-
neys (Traver et al., 2003).
Importance of Niche-Associated Cells in Controlling
HSC Fate
In the adult bone marrow, the sinusoidal vessels form a
complex network in close proximity to the HSCs. In such
a ‘‘perivascular microenvironment’’ (Kiel et al., 2005; Nom-
bela-Arrieta et al., 2013), endothelial cells (ECs) with
distinct properties nurture and expand the hematopoietic
stem and progenitor cells (HSPCs). Studies have shown
that, in addition to the ECs, many other cell types within
the perivascular niche (e.g., stromal cells, sympathetic
nerves, osteoblasts) can support HSPCs by supplementing
factors including KIT ligands and CXCL12. Many of these
studies relied on visualizing the exogenous HSPCs in a
bone explant (Sugiyama et al., 2006; Kohler et al., 2009;
Lo Celso et al., 2009; Xie et al., 2009; Mendez-Ferrer
et al., 2010; Ding et al., 2012; Ding and Morrison, 2013;
Greenbaum et al., 2013). Directly visualizing the endoge-
nous marrow in a living organism has always been a major
challenge in the field for a rigorous analysis of the dynamic
cell-cell interactions that are prerequisite to determining
the fate and engraftment potential of HSCs.
To this end, our laboratory has utilized the developing
zebrafish as a model which, by virtue of being transparent,
offers a distinct advantage over the mouse model in visual-
izing the sequential cell-cell interactions during HSC
migration and niche engraftment at a spatiotemporal reso-
lution. By using a regulatory element from the first intron
of the mouse Runx1 locus (+23 kb downstream of the P1
promoter), two transgenic zebrafish lines were generated
to drive either EGFP (Runx:GFP) ormCherry (Runx:mCherry)
to specifically mark the HSCs (Tamplin et al., 2015). HSCs
marked by these reporters also express major definitive
stem cell markers, such as cMYB and CD41, in the major
embryonic hematopoietic sites, e.g., CHT, DA, kidney,
and thymus. The Runx+ cells are functional, since 3months
post transplantation donor cells produced progeny of all
the downstream lineages. Limit dilution assays estimated
the stem cell frequency within the Runx+ cells to be 1 in
3 in the embryo and 1 in 35 in the adult. Coupled with
state-of-the art high-resolution time-lapse microscopy,
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the Runx-transgenic lines provided an opportunity to track
endogenous HSCs in the live embryo and monitor the
dynamic interactions with the niche. By intercrossing
Runx:EGFP to an FLK1:mCherry line (a vascular reporter
that marks ECs), we were able to discover striking HSC-EC
interactions during HSC travel through circulation to the
CHT. As nascent HSCs migrate into CHT, distinct steps of
lodgment and niche engraftment can be visualized, begin-
ning with luminal adherence and transendothelial migra-
tion. Once in the extravascular space, HSCs interact with
the endothelial cells on their abluminal surface. At least
five endothelial cells remodel to form a pocket around a
specific HSC. In addition, upon intercrossing Runx:EGFP
and CXCL12A:dsRedII (which marks the mesenchymal fi-
broblasts) transgenic lines, we were able to detect novel
HSC-mesenchymal stromal cell interactions, where two
stromal cells in close proximity to anHSC oriented the sub-
sequent division plane of the HSC, presumably by deter-
mining HSC polarity. Finally, the Runx:EGFP transgenic
line proved to be an excellent tool for a chemical genetic
screen to identify small molecules that modulate the
HSC-niche interactions observed in the embryo. This
study, apart from validating transforming growth factor b
as a negative regulator of HSC proliferation, identified a
novel compound, lycorin, which over time strikingly
increased the number of HSCs not only in the CHT but
also in the kidney marrow of 4-month-old adult fish. This
unique study identified novel HSC-niche interactions
that lead to long-term changes in the size of the stem cell
Transparent Casper zebrafish allow visualization of blood in the
adult animal. GFP reporter for the hemoglobin locus control
region (LCR-GFP) is expressed in all zebrafish red blood cells.
The inset shows blood circulating through the tail fin.
Dr. Zon is the Grousbeck Professor of Pediatric Medicine at
Harvard Medical School, Investigator at Howard Hughes Medical
Institute, and Director of the Stem Cell Program at Boston
Children’s Hospital. Dr. Zon received his B.S. in chemistry and
natural sciences from Muhlenberg College (1979) and his M.D.
from Jefferson Medical College (1983). He subsequently did an
internal medicine residency at New England Deaconess Hospital
(1986) and a fellowship in medical oncology at Dana-Farber
Cancer Institute (1989). His postdoctoral research was in
Stuart Orkin’s laboratory (1990). Dr. Zon is internationally-
recognized for his pioneering work in stem cell biology and
cancer genetics. He has been the preeminent figure in estab-
lishing zebrafish as an invaluable genetic model for the study of
the blood and hematopoietic development. He is founder and
former president of the International Society for Stem Cell
Research and chair of the Executive Committee of the Harvard
Stem Cell Institute. In 2005, he completed a term as President
of the American Society for Clinical Investigation. That same
year, Dr. Zon was elected to the Institute of Medicine of the
National Academies. In 2008, Dr. Zon was elected to the
American Academy of Arts & Sciences. In 2010, Dr. Zon was
awarded the E. Donnall Thomas Lecture and Prize from American
Society of Hematology. In 2013, Dr. Zon received the ISEH
Donald Metcalf Lecture Award. Other recent awards include the
2014 Boston Children’s Hospital Post-Doctoral Association
Mentoring Award and the National Cancer Institute’s Alfred G.
Knudson Award (2015).
1466 Stem Cell Reports j Vol. 8 j 1465–1471 j June 6, 2017
Stem Cell Reports
Perspective
pool into adulthood. Currently experiments are investi-
gating the influence of other cell-types in theHSCmicroen-
vironment that could potentially alter HSC fate.
Clonality: Establishing and Maintaining an
Appropriate Pool of HSCs
The question of how an appropriate pool of HSCs is estab-
lished and maintained is of both basic and clinical impor-
tance. In several blood cancers such as multiple myeloma,
acute myeloid leukemia and chronic lymphocytic leuke-
mia somatic mutations have been identified which are
thought to lead to an expansion of a malignant clone,
often originating from a hematopoietic stem or progenitor
cell. However, the same mutations can also be present in
healthy, asymptomatic individuals (Jaiswal et al., 2014).
Therefore, additional experimental systems are needed to
further investigate genetic and epigenetic players driving
clonal malignant states. Traditional clonal analysis during
native hematopoiesis has been hampered by the fact that
being a liquid tissue, spatial information cannot be used
to infer lineage relationships. Various innovative ap-
proaches have recently given novel insights into the clon-
ality of native hematopoiesis such as using specific HSC
promoters (Busch et al., 2015) or utilizing transposon
induced DNA barcoding to track hematopoietic clones
(Sun et al., 2014). In addition, fluorescent protein expres-
sion has been used for clonality studies in a system called
Brainbow, originally developed to monitor lineage rela-
tionships within the nervous system (Livet et al., 2007).
In a Brainbow transgenic animal, there are several cassettes
of three genes encoding distinct fluorescent proteins and
flanked by different loxP sites. Induction of Cre-recombi-
nase leads to a random recombination event at any of the
loxP sites that results in various color combinations in
each cell, essentially color-barcoding the cell.CRE recombi-
nase can be tissue specific if expressed under specific pro-
moters. Progeny of a color-barcoded hematopoietic cell
will have the same color, revealing the clonal nature of a
particular lineage. During development in zebrafish, for
example, the timing of CRE recombinase induction allows
one to determine the number of HSC clones in a defined
developmental stage by tracking the clonal diversity
of adult hematopoietic cells. Using this color-barcoding
method, our studies found that there are about 30 HSC
clones during their birth in the aorta-gonad-mesonephros
(AGM) (Henninger et al., 2017). Furthermore, our system
allowed tracking clonal output of HSPCs over time and
showed that clonality of peripheral blood remained stable
during normal adult hematopoiesis. Stressful stimuli,
such as irradiation or transplantation, reduced the number
of HSPC clones, likely because of selection that leads to the
dominance of one clone over the others. The shift in clonal
compositions was apparent by an increased presence of a
color-barcoded hematopoietic output. We are now trying
to exploit this system to model malignant clonal hemato-
poietic states in adult zebrafish by introducing various
putative mutations identified from human blood cancers.
In comparison with mammalian in vivo models, a greater
number of mutational combinations can be tested in
a non-transplanted, native hematopoiesis setting. For a
typical experiment, we can introduce up to 20 different
mutations in about 50 zebrafish, and multiple studies can
be run in parallel. A big advantage of the Brainbow system
over sequencing-based lineage-tracking approaches is that
flow cytometry-based cell sorting allows the isolation of
dominant clones. These cells can then be used for further
molecular analyses or be subjected to functional testing
in transplantation assays. A recent study has used the
Brainbow system to track hematopoietic clonal output
in the mouse, mostly using transplantations (Yu et al.,
2016). Integrating data across various lineage-tracing
techniques in both native hematopoiesis and during trans-
plantation will allow us to further unravel mechanisms
controlling HSC numbers as well as their dynamics and
clonal output.
Chemical Screens: Identifying Conserved Small-
Molecule Regulators of HSC Function
Because of their external development, embryos of lower
vertebrates such as zebrafish can be easily manipulated.
For example, drugs can be added in a precisely timed
manner to the media in which the embryos are incubated.
The ease by which zebrafish embryos can be treated with
chemicals has been utilized in more than 60 phenotypic
chemical screens in the past 15 years (Rennekamp and Pe-
terson, 2015). Similar to traditional forward genetic screens
in model organisms, a specific phenotype is chosen (e.g.,
numbers of HSCs in the developing embryo) and a library
of chemicals is screened for candidates that can affect this
phenotype. Our laboratory alone has conducted around
20 chemical screens, and we believe that the zebrafish is
arguably the best model for in vivo phenotypic chemical
screening.
A chemical screen targeted at modulators of HSC
numbers during embryonic development identified prosta-
glandin E2 (PGE2) a small-lipid mediator (North et al.,
2007). Out of a library of around 2,500 chemicals, 12% of
all hits were part of the prostaglandin pathway. We further
discovered that during adult regeneration, a pulse of PGE2
conferred an advantage in hematopoietic regenerative ca-
pacity in both zebrafish and mice (Goessling et al., 2009;
Goessling et al., 2011). Although studies from the 1970s
and 1980s had implicated PGE2 in hematopoiesis and re-
covery after irradiation, a clear link between HSCs and
PGE2 was missing (Feher and Gidali, 1974; Gentile et al.,
1983; Hanson and Ainsworth, 1985). Together with others
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we were the first to demonstrate a direct effect of PGE2 on
HSCs, via limit dilution competitive reconstitution assays
(North et al., 2007; Hoggatt et al., 2009). Ex vivo treatment
of donor bone marrow can increase the number of func-
tional HSCs by 4-fold. Because of promising results in
animal models, PGE2 is now under clinical investigation
to improve human HSC transplants (Cutler et al., 2013).
This compound also illustrates the strength of starting
with in vivo animal models early in the discovery process.
PGE2 was the first compound discovered in a zebrafish
chemical screen that entered clinical trials. The transition
from the initial zebrafish studies to the human trial took
only 2.5 years.
Zebrafish lends itself to chemical screens not only in the
embryo but also in the adult. A zebrafish mutant called
‘‘Casper’’ was developed that is completely transparent
and allows monitoring of adult tissue in the living organ-
ism (White et al., 2008). This fishmodel permitted tracking
and measurement of HSC engraftment after transplanta-
tion in an adult live animal (Li et al., 2015). In a competi-
tive transplant experiment we screened 480 chemicals for
an advantage in engraftment. We discovered other lipid
mediators, epoxyeicosatrienoic acids (EETs), to be potent
enhancers of HSC engraftment in zebrafish. Again, the
beneficial effect on HSCs was conserved in mouse hemato-
poietic transplantations. As a member of the eicosanoid
family, EETs are related to PGE2, but the ultimate biochem-
ical pathways regulating synthesis and degradation are
distinct. EETs and PGE2 bind to different receptors (G-pro-
tein-coupled receptors [GPCRs]) and elicit distinct immedi-
ate downstream signaling. It is intriguing to consider how
two lipids through different immediate actions can elicit
the same overall phenotype, i.e., a net positive effect on
HSC regeneration. PGE2 is likely acting directly on the
HSPCs by enhancing long-term engraftment. It will be
interesting to similarly identify a target cellular population
of EETs. Determining the receptor for EETs, an as to this
date unknown GPCR, will be key for further functional
studies. Overall, zebrafish have been successfully used
repeatedly as a potent in vivo screening platform to
identify chemicals affecting conserved mechanisms of
regeneration.
Niche-Associated Signaling Factors that Influence HSC
Regeneration and Differentiation
The inflammatory small molecules EETs and PGE2 identi-
fied in our chemical screen are likely also endogenously
activated during hematopoietic regeneration. One source
of these lipid mediators are niche cells. Our results suggest
that the interaction of HSCs and niche cells, such as a rapid
remodeling of endothelial cells around a stem cell, may
form localized pockets that could effectively increase the
concentration of local growth factors and signaling mole-
cules. It is tempting to speculate that PGE2 and EETs as
well as other signaling pathways including bone morpho-
genetic protein (BMP), WNT, and Notch, exert spatiotem-
poral control over hematopoietic stem cell self-renewal,
differentiation, and regeneration. The hematopoietic sys-
tem regenerates after sublethal doses of irradiation or after
transplantation. During this regeneration, ligands for the
developmental signaling pathways and small lipid ligands
are upregulated in the stem cell niche, and this facilitates
the recovery (Lenox et al., 2005; Congdon et al., 2008;
Porter et al., 2013). We have investigated the mechanism
of ligand-induced signaling transcription factors on the
intrinsic hematopoietic program (Trompouki et al., 2011).
Transgenic zebrafish lines that overexpress positive and
negative regulators of the WNT and BMP pathway with a
heat-shock promoter were subjected to a sublethal dose
of irradiation and the recovery was monitored. There was
an acceleration of precursor recovery in the presence of
WNT or BMP, and treatment of WNT and BMP inhibitors
partially blocked recovery. Based on qPCR analysis, higher
levels of cell-specific regulators such as MYB, RUNX1,
LMO2, and SCL occurred with stimulation of the WNT
and BMP pathways, providing evidence that the WNT
and BMP pathways stimulate the intrinsic hematopoietic
program during regeneration.
WNT and BMP signal transduction pathways terminate
with specific signaling transcription factors, TCF7L2 and
SMAD1, respectively. To understand the targets of WNT
and BMP stimulation in hematopoietic cells, chromatin
immunoprecipitation sequencing experiments to evaluate
DNA binding of TCF7L2 and SMAD1 were performed
(Trompouki et al., 2011). Both signaling transcription fac-
tors bind adjacent to the erythroid-specific transcription
regulators GATA2 and GATA1 on erythroid-specific genes
in erythroleukemic K562 cells; however, in myeloleukemic
U937 cells, their binding shifts to myeloid-specific genes in
regions that are co-occupied by the myeloid master tran-
scription factor CEBP-a. This suggests that the cell-specific
transcription factors recruit the signaling transcription fac-
tors to local areas of the genome to reinforce the intrinsic
hematopoietic program during regeneration, conferring
an advantage to the recovering cells. Current experiments
are under way to understand the mechanisms that influ-
ence recruitment of signaling transcription factors by cell
type-specific factors at the critical genomic sites during
HSC differentiation.
Many signaling molecules including WNT, BMP, PGE2,
and EET have all been described to play a beneficial role
during HSC self-renewal and regeneration (Zon, 2008).
Since all of these secreted factors lead to the same
outcome—increased regeneration—we are now trying to
assess at which point these pathways converge. Initial
signaling is different and leads to the activation of distinct
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transcription factors. One possible model would be that
these transcription factors are recruited to certain impor-
tant sites called ‘‘signaling centers’’ and then drive a com-
mon regenerative gene expression signature. Identifying
these putative genomic loci as well as their target genes
could reveal fundamental principles governing hematopoi-
etic regeneration. Many open questions remain, such as
potential feedback signaling between niche and HSCs,
coordination of different temporal kinetics between these
pathways, and possible sequential activation of different
signaling pathways.
Perspective and Future Implications
Our research strives to elucidate fundamental principles
of HSC biology with the potential to have a clinical impact.
To unravel the role of the microenvironment for HSCs a
direct visualization of in vivo HSC behavior would be the
most straightforward, yet almost impossible strategy in a
mammalian system. Utilizing the transparent zebrafish
embryos coupled with a spinning-disk confocal micro-
scope, we are able to visualize the step-by-step events of
the HSC-niche interactions in vivo. This provides a high-
est-resolution image of a stem cell niche in any vertebrate
species, utilizing electron microscopic resolution of stem
cells as they arise and migrate during development. Deter-
mining all of the cellular players that constitute the niche
and evaluating their behavior in real time is vital for under-
standing the behavior of regenerative stem cells.
Being able to model development and maintenance of
HSC clones throughout an organism’s lifespan is critical
to testing genetic risk factors affecting their function. Using
the Brainbow system, we have developed a novel way to la-
bel and track HSC clones in their native state. We believe
that the zebrafish Brainbow system is ideal for prospec-
tively introducingmutations intoHSPCs and tracking their
effect on clonality during native hematopoiesis. We expect
that our findings will be also applicable to human hemato-
poietic malignancies.
Our studies have demonstrated the value of screening
and evaluating pathways governing HSC self-renewal/
differentiation in the zebrafish system, capitalizing on
the excellent genetics and developmental biology of the or-
ganism, and utilizing the mouse and human systems to
validate our observations and probe mechanism. This
approach led to the discovery of PGE2 and EETs as potent
regulators of HSC induction during embryogenesis and
engraftment in adults. PGE2 has shown significant promise
to stimulate the engraftment process directly by increasing
long-term self-renewal of HSCs, an essential step in success-
ful clinical development. In addition to PGE2, our strategy
has significant potential to identify other small molecules
that would improve therapy for patients who have under-
gone HSC transplantation. Our studies with BMP and
WNTsignaling in human erythroid progenitors have docu-
mented the surprising co-binding of cell-specific and
signaling-induced transcription factors to blood-specific
genes, providing a mechanism by which the cell-specific
program can be stimulated by developmental growth fac-
tors during regeneration. Given our observation that the
interaction betweenmaster and signaling transcription fac-
tors are highly conserved in human, mouse, and zebrafish
hematopoietic cells, our approach should be able tomanip-
ulate the process for the benefit of treating blood diseases
and for improvingmarrow and cord blood transplantation.
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